HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of septicemia with latamoxef. Multicentric study of 60 cases].

Abstract
Sixty patients including forty two males and eighteen females, age range: 18-87 years, received antibacterial single drug treatment with latamoxef for septicemia. Forty nine patients had underlying conditions including multiple trauma, neoplasm, cardiovascular, metabolic and respiratory tract diseases. Causative pathogens were isolated in all cases. The predominant isolates were E. coli (thirty), Klebsiella pneumoniae (tent) and Enterobacter (seven). A single organism was isolated in fifty seven cases; in the other three cases two organisms were isolated from blood cultures. Mean daily dosage was 46.6 +/- 6.1 mg . kg-1 (range: 14-113 mg . kg-1). In the majority of cases (fifty two) dosage was 3 g . d-1 or less; in thirty cases it was no higher than 2 g . d-1. Duration of therapy ranged from six to thirty eight days. Serum titer was measured in many cases and latamoxef blood levels were assayed in nine patients. A satisfactory clinical response was achieved in fifty eight cases and fifty eight bacteriological cures were also obtained. There was no statistically significant difference in therapeutic response between the 2 g and 3 g daily dosage groups. Tolerance was very good; untoward effects were few and required drug discontinuation in one case only.
AuthorsJ C Salord, M Armengaud, J Aubertin, A Bertrand, C Carbon, J B Dureux, M Goulon, F Gouin, B Leng, J Motin, Y Mouton, H Portier, P Veyssier
JournalAnnales francaises d'anesthesie et de reanimation (Ann Fr Anesth Reanim) Vol. 1 Issue 6 Pg. 655-60 ( 1982) ISSN: 0750-7658 [Print] France
Vernacular TitleTraitement des septicémies par le latamoxef. Etude multicentrique de soixante cas.
PMID6224444 (Publication Type: Case Reports, Comparative Study, English Abstract, Journal Article)
Chemical References
  • Cephalosporins
  • Cephamycins
  • Moxalactam
Topics
  • Adolescent
  • Adult
  • Aged
  • Blood Bactericidal Activity
  • Cephalosporins (therapeutic use)
  • Cephamycins (blood, therapeutic use)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Moxalactam
  • Sepsis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: